Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participantsZonglin Li, Linong Ji, Chu Lin et al.|Expert Opinion on Investigational Drugs|2022Cited by 11
Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participantsZonglin Li, Linong Ji, Fang Lv et al.|Figshare|2022Cited by 0